Quince Therapeutics Inc.

NASDAQ: QNCX
Share price (8/14/25): $1.68
Market cap (8/14/25): $90.2 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Shelf registration

Exempt offering of securities

Registration of securities for employees

Prospectus supplement for primary offering

Ownership Filter

Nantahala Capital Management, LLC

Ryan Charles S.

News Filter

Provides Business Update and Reports Second Quarter 2025 Financial Results

Completes Enrollment in Pivotal Phase 3 NEAT Clinical Trial in Ataxia-Telangiectasia

Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Shareholder Vote Results

Provides Business Update and Reports First Quarter 2025 Financial Results

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC